Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 0 | 1,260 | 0 | 0 | 0 |
| Gross Profit | N/A | 1,260 | N/A | N/A | N/A |
| Operating Expenses | 24,614 | 17,208 | 22,803 | 29,897 | 21,714 |
| Operating Income | -24,614 | -15,948 | -22,803 | -29,897 | -21,714 |
| Other Income | -1,623 | 574 | -83 | 479 | 433 |
| Pre-tax Income | -26,237 | -15,374 | -22,886 | -29,418 | -21,281 |
| Net Income Continuous | -26,237 | -15,374 | -22,886 | -29,418 | -21,281 |
| Net Income | $-26,237 | $-15,374 | $-22,886 | $-29,418 | $-21,281 |
| EPS Basic Total Ops | -1.66 | -1.08 | -2.06 | -2.91 | -2.49 |
| EPS Basic Continuous Ops | -1.66 | -1.08 | -2.06 | -2.92 | -2.49 |
| EPS Diluted Total Ops | -1.66 | -1.08 | -2.06 | -2.91 | -2.49 |
| EPS Diluted Continuous Ops | -1.66 | -1.08 | -2.06 | -2.92 | -2.49 |
| EPS Diluted Before Non-Recurring Items | -1.60 | -1.08 | -2.06 | -2.91 | -2.49 |
| EBITDA(a) | $-24,548 | $-15,878 | $-22,732 | $-29,839 | $-21,686 |